TNFSF10 and Alzheimer disease: It is noteworthy that a TRAIL-neutralizing treatment results in a significant decrease of both cellular and soluble factors contributing to brain inflammation [11], suggesting that TRAIL is a coordinating molecule in the inflamed brain, as demonstrated, for example, by its capability to control peripheral immunocytes trafficking into the brain of 3xTg-AD mice [54].